Genolution Signs Share Purchase Agreement Involving Change of Largest Shareholder
On January 20, Genolution announced that a share purchase agreement involving a change of the largest shareholder had been signed.
Hoyl Biomed stated that it would transfer 810,372 shares of Genolution to Co-CEO Kim Kiok at 1,851 won per share, for a total of 1.5 billion won.
The payment is scheduled for February 19. The shares will be delivered simultaneously with the payment.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
After the transaction, the largest shareholder of Genolution will be Co-CEO Kim Kiok. Kim is expected to hold 2,229,440 shares, representing 11.62% ownership.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.